Response To Checkpoint Inhibition In Lung Cancer With Molecular Driver Alterations.

Amanda Tufman,Kathrin Kahnert,Diego Kauffmann-Guerrero, Benjamin-Alexander Bollmann,Simone Reu,Zulfiya Syunyaeva,Christian P. Schneider,Farkhad Manapov,Thomas C. Wehler,Rudolf M. Huber,Heiko Golpon

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 3|浏览14

暂无评分

摘要

e21071Background: Checkpoint inhibitors are widely used in NSCLC. While there is evidence that EGFR mutation driven tumours respond poorly to checkpoint inhibition, little is known about the sensit...

查看译文

关键词

lung cancer,molecular driver alterations

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要